Direct Discrimination of Quantum States by the Human Eye

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre for Eye and Vision Research

About this trial

Age-related macular degeneration (AMD), is a debilitating eye disease that causes a loss of central vision. The prevalence of AMD increases exponentially with age and causes a significant impact through both medical expenses and the social and economic costs associated with vision loss. AMD is the global leading cause of blindness among people over the age of 60. Detection of this eye disease at early stages coupled with prompt treatment can prevent vision loss; however, modern diagnosis methods are ineffective at diagnosis of AMD before vision loss occurs. While a range of available treatment options has been effective at slowing vision loss due to AMD, no treatment exists which can recover lost vision. The investigators propose to apply tools developed in quantum information science to diagnose AMD before vision has been affected, drastically improving health outcomes for patients with AMD.

Eligibility criteria

Qualifiers

Participants who are clinically diagnosed with a vision disease affecting their macula

Older adults who are matched for age.

Participants who are clinically diagnosed with glaucoma

Participants who have normal vision.

Disqualifiers

Participants with any additional eye diagnosis or condition

Trial design

Treatments tested in this trial

  • Structured Light Imaging Microscopy

Treatment groups

50 Participants
are divided into 1 treatment group

Sponsors and collaborators

Centre for Eye and Vision Research

Lead sponsor

University of Waterloo

Collaborator

The Hong Kong Polytechnic University

Collaborator